study,trt,class,mean,sd,se,n
abou-raya 2012,placebo,placebo,30.3,9.8,,144
abou-raya 2012,duloxetine,snri,24.6,8.4,,144
arnold 2012: 2,placebo,placebo,38.19,,0.46,255
arnold 2012: 2,esreboxetine,snri,38.49,,0.48,241
arnold 2012: 2,esreboxetine,snri,39.51,,0.47,247
arnold 2012: 2,esreboxetine,snri,38.28,,0.47,250
ash 1999,placebo,placebo,1.82,0.89,,23
ash 1999,dothiepin,tca,1.85,0.88,,25
boyle 2012,pregabalin,nonad,31.1,,10.9,19
boyle 2012,amitriptyline,tca,38.5,,8.8,23
boyle 2012,duloxetine,snri,36.6,,9.4,23
cardenas 2002,placebo,placebo,53.7,18.3,,40
cardenas 2002,amitriptyline,tca,66.3,16.7,,44
carette 1994,placebo,placebo,9.01,10.6,,36
carette 1994,amitriptyline,tca,8.3,8.25,,78
carette 1994,cyclobenzaprine,nonad,6.65,6.82,,70
dickens 2000,placebo,placebo,52.4,13.6,,48
dickens 2000,paroxetine,ssri,50.2,15.2,,44
gilron 2009,gabapentin,nonad,61.6,,2.6,46
gilron 2009,nortriptyline,tca,61.7,,2.5,50
gilron 2009,gabapentin + nortriptyline,tca,64.3,,2.5,50
gilron 2016,placebo,placebo,52.9,,3.1,39
gilron 2016,pregabalin,nonad,57.1,,3.1,39
gilron 2016,duloxetine,snri,61.4,,3.2,39
gilron 2016,pregabalin + duloxetine,snri,65.3,,3.3,39
goodkin 1990,placebo,placebo,22.84,12.72,,19
goodkin 1990,trazodone,sari,25.41,17.04,,21
gould 2020,placebo,placebo,9.5,5.15,,33
gould 2020,desipramine,tca,7.65,5.99,,37
gould 2020,benzotropine mesylate + cognitive behavioural therapy,nonad,9.33,5.74,,34
gould 2020,desipramine + cognitive behavioural therapy,tca,8.66,5.79,,37
hadianfard 2012,acupuncture,nonad,3.5,2.5,,15
hadianfard 2012,fluoxetine,ssri,3.3,2.2,,15
hannonen 1998,moclobemide,maoi_rev,19.6,17.6,,43
hannonen 1998,amitriptyline,tca,20.7,18.3,,42
hannonen 1998,placebo,placebo,25.4,17.7,,45
hudson 2021,nortriptyline,tca,39.6,24.4,,102
hudson 2021,placebo,placebo,41.9,24.2,,103
hussain 2011,melatonin,nonad,6.25,,0.35,27
hussain 2011,fluoxetine,ssri,5.5,,0.27,24
hussain 2011,fluoxetine + melatonin,ssri,5.08,,0.28,27
hussain 2011,fluoxetine + melatonin,ssri,3.1,,0.23,23
keefe 2010,placebo,placebo,4.46,9.37,,28
keefe 2010,sertraline,ssri,3.06,7.72,,30
keefe 2010,coping skills training,nonad,3.64,5.34,,29
keefe 2010,coping skills training + sertraline,ssri,2.15,3.78,,28
khoromi 2007,placebo,placebo,30.5,15.9,,28
khoromi 2007,morphine,nonad,25.7,16.5,,28
khoromi 2007,nortriptyline,tca,27.5,16.7,,28
khoromi 2007,morphine + nortriptyline,tca,27.4,15.4,,28
lee 2010,placebo,placebo,55.1,14.7,,21
lee 2010,venlafaxine,snri,55,14.8,,22
matthey 2013,placebo,placebo,38.7,7.3,,39
matthey 2013,milnacipran,snri,38,7.7,,38
muller 2008,placebo,placebo,13.4,1.5,,26
muller 2008,escitalopram,ssri,6.9,1.6,,25
nct 2011,placebo,placebo,26,18,,12
nct 2011,milnacipran,snri,15,10,,26
robinson 2004,placebo,placebo,79.1,3.3,,18
robinson 2004,amitriptyline,tca,74.5,18.8,,19
schukro 2016,placebo,placebo,31.3,9.3,,21
schukro 2016,duloxetine,snri,36,10.9,,21
sofat 2016,placebo,placebo,508.7,309.19,,22
sofat 2016,pregabalin,nonad,362.2,192.64,,22
sofat 2016,duloxetine,snri,496.4,360.18,,21
spinhoven 2010,placebo,placebo,7,3.3,,23
spinhoven 2010,paroxetine,ssri,4.7,3,,23
spinhoven 2010,cognitive behavioural therapy,nonad,4.9,3.9,,23
suttiruksa 2016,placebo,placebo,58,7.2,,13
suttiruksa 2016,mirtazapine,nassa,80,5.1,,13
suttiruksa 2016,mirtazapine,nassa,76.7,6,,14
tetreault 2018,placebo,placebo,39.05,18.85,,20
tetreault 2018,duloxetine,snri,39.89,17.43,,19
urquhart 2018,placebo,placebo,5.9,0.6,,74
urquhart 2018,amitriptyline,tca,4.7,0.5,,72
vranken 2011,placebo,placebo,38,25,,23
vranken 2011,duloxetine,snri,41,27,,21
wolfe 1994,placebo,placebo,0.8,0.76,,9
wolfe 1994,fluoxetine,ssri,0.7,0.43,,15